Select Medical Holdings (SEM) Cash from Financing Activities (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Cash from Financing Activities data on file, last reported at $18.0 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 63.57% year-over-year to $18.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$194.5 million (up 50.74% YoY) and the FY2025 annual result came in at -$163.2 million, up 47.57% from the prior year.
• Cash from Financing Activities rose to $18.0 million in Q1 2026 per SEM's latest filing, from -$31.0 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $133.0 million in Q1 2024 and bottomed at -$205.5 million in Q2 2024.
• The 5-year median for Cash from Financing Activities is -$46.5 million (2025), against an average of -$48.2 million.
• The widest annual swing landed in 2023, when Cash from Financing Activities plunged 400.5%; it then surged 3788.86% in 2024.
• Tracing SEM's Cash from Financing Activities over 5 years: stood at $34.4 million in 2022, then sank by 400.5% to -$103.3 million in 2023, then tumbled by 77.18% to -$183.0 million in 2024, then soared by 83.08% to -$31.0 million in 2025, then surged by 157.99% to $18.0 million in 2026.
• Per Business Quant, the three latest SEM Cash from Financing Activities figures stand at $18.0 million (Q1 2026), -$31.0 million (Q4 2025), and -$135.0 million (Q3 2025).

Peer Comparison